Portugal: will the life science sector see upswing amid funding worries? By Roohi Mariam Peter 13 minutesmins April 1, 2026 -Updated: onApril 7, 2026 13 minutesmins Share WhatsApp Twitter Linkedin Email Photo credits: Annie Spratt (Unsplash) Newsletter Signup - Under Article / In Page"*" indicates required fieldsCompanyThis field is for validation purposes and should be left unchanged.Subscribe to...
**Steelman:** Portugal’s life science sector is at a pivotal juncture, with tangible growth in research output, patent filings, and high-profile acquisitions like BioNtech’s CellmAbs deal. The hosting of BIO-Europe Spring 2026 and the emergence of specialized VC funds like Biovance Capital signal a maturing ecosystem. The sector’s strengths—strong academic research, cost-effective talent, and strategic geographic positioning—are undeniable. Yet, the narrative hinges on a critical tension: Portug...